ALX Oncology Holdings Inc. (ALXO) vs Cardiol Therapeutics Inc. (CRDL)
A side-by-side comparison of ALX Oncology Holdings Inc. and Cardiol Therapeutics Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
ALXO
ALX Oncology Holdings Inc.
$1.16HealthcareDelayed quote: Oct 6, 2026, 10:15 AM EDT
CRDL
Cardiol Therapeutics Inc.
$1.32HealthcareDelayed quote: Oct 6, 2026, 10:09 AM EDT
Total return — ALXO vs CRDL
growth of $100 · dividends reinvested · last 6yALXO -96.0% (-41.4%/yr)CRDL -22.8% (-4.2%/yr)CRDL compounded faster over this window
Log scale — wide-divergence pair
ALXO CRDL
ALXO vs CRDL: by the numbers
- •ALXO is the larger company ($156M vs $152M market cap).
Metrics side by side
Valuation
| Metric | ALXO | CRDL |
|---|---|---|
| P/B ratio | 1.15 | 8.96 |
Profitability
| Metric | ALXO | CRDL |
|---|---|---|
| Gross margin | 0.00% | 0.00% |
| Operating margin | 0.00% | 0.00% |
| Net margin | 0.00% | 0.00% |
| ROE | -59.40% | -155.34% |
| ROIC | -56.53% | -165.56% |
Growth (annualized)
| Metric | ALXO | CRDL |
|---|---|---|
| Total return CAGR (5Y) | -56.07% | -18.36% |
Frequently asked
- How have ALXO and CRDL total returns compared?
- Over the past 5 years, ALXO delivered -56.07% and CRDL delivered -18.36% annualized total return. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.